A Target Trial Emulation of GLP1RA, SGLT2i or DPP4i as Add on Treatment in CKD

In this Editors' Choice Podcast, the CJASN EIC, Connie Rhee, and the Deputy Editors, Baback Roshanravan and Sagar Nigwekar, highlight three original research manuscripts focused on the theme of advancing kidney health equity in diverse populations.

In this podcast, Dr. Allon and Dr. Lee summarize the main findings from their study on "Trends in Vascular Access Placement among Patients Initiating Hemodialysis with a Catheter" on behalf of their colleagues.

Drs. Ficociello, Zhang, & Kalantar-Zadeh summarize the main findings from their study, "Hemodialysis Modality and Mortality Outcomes among Incident Dialysis Patients: An International Cohort Study Comparing High-Volume Hemodiafiltration and Hemodialysis."

In this podcast, Drs. Roumie and Hung summarize the main findings from their study on "Target Emulation Trial: GLP1RA, SGLT2i, DPP4i for Kidney Outcome Prevention" on behalf of their colleagues.

In this podcast, Dr. Yu summarizes the main findings from his study on the "Relationship between Total Kidney Volume and eGFR in Autosomal Dominant Polycystic Kidney Disease" on behalf of his colleagues.

In this podcast, Dr. Rebholz summarizes the main findings from her study on "Proteomic Markers of Dietary Patterns, CKD Progression, and Mortality in the CRIC Study" on behalf of her colleagues.

Dr. Saland summarizes the main findings from his study on "Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1.

Dr. McCausland summarizes the main findings from his study on "Effect of finerenone on eGFR slope across different levels of baseline albuminuria and eGFR: Insights from FINEARTS-HF" on behalf of his coauthors.

Dr. Parikh, Dr. Malhotra, and Dr. Thiessen Philbrook summarize the main findings from their study on "Dynamic Risk Prediction of Graft Failure After Deceased Donor Kidney Transplant" on behalf of the authors.

Drs. Dagmara Borzych-Dużałka and Khandelval summarize the main findings from their study on "Early-Start vs. Late-Start Icodextrin for Children Receiving Chronic Peritoneal Dialysis: Findings from the International Pediatric Peritoneal Dialysis Network".